Immunic, Inc.IMUXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-3.81%
↓ 132% below average
Average (9y)
12.04%
Historical baseline
Range
High:71.63%
Low:-36.90%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -3.81% |
| 2023 | 16.78% |
| 2022 | 16.59% |
| 2021 | 58.18% |
| 2020 | 71.63% |
| 2019 | -9.32% |
| 2018 | -36.90% |
| 2017 | 30.94% |
| 2016 | -24.46% |
| 2015 | 0.74% |